Perioperative hypothermia remains a prevalent complication in surgical patients, associated with significant morbidity and adverse outcomes. Effective risk stratification is crucial for targeted prevention, timely intervention, and improved perioperative care. This review synthesizes current epidemiological data, pathophysiological mechanisms, identified risk factors, clinical manifestations, diagnostic approaches, management strategies, and recent advances in perioperative hypothermia, incorporating guideline-based recommendations and practical insights for clinicians. Emphasis is placed on individualized risk assessment and evidence-driven protocols to optimize patient safety and minimize perioperative complications.
Perioperative hypothermia, defined as a core body temperature below 36°C during the perioperative period, is a common but frequently underestimated complication in surgical practice. Hypothermia during or after anesthesia can lead to a spectrum of deleterious effects, including coagulopathy, increased blood loss, surgical site infections, prolonged recovery, and cardiovascular instability. Despite advances in perioperative monitoring and warming techniques, hypothermia continues to impact patient outcomes, underscoring the necessity for precise risk stratification and individualized prevention strategies. This review aims to provide clinicians with an updated, evidence-based framework for identifying, assessing, and mitigating the risk of perioperative hypothermia.
The incidence of inadvertent perioperative hypothermia has been reported to range from 20% to 70%, depending on surgical type, patient demographics, and institutional protocols. While the prevalence has declined with increased awareness and routine warming measures, certain patient populations remain disproportionately affected. Recent multicenter studies highlight that elderly patients, those undergoing major or prolonged procedures, and individuals with significant comorbidities are at greater risk. The disease burden extends beyond acute perioperative complications, contributing to increased healthcare costs, longer hospital stays, and heightened rates of postoperative morbidity and mortality.
The pathogenesis of perioperative hypothermia is multifactorial. Anesthetic agents impair thermoregulatory control by decreasing the shivering threshold, promoting peripheral vasodilation, and inhibiting hypothalamic responses to cold stress. Operating room environments, typically maintained at lower temperatures, exacerbate heat loss through radiation, convection, conduction, and evaporation. Surgical exposure, large incisions, and the use of cold intravenous fluids or irrigation solutions further contribute to intraoperative heat loss. The diminished metabolic rate during anesthesia, coupled with impaired behavioral responses, places surgical patients at inherent risk for rapid core temperature decline.
Risk stratification for perioperative hypothermia requires careful evaluation of patient-specific, procedural, and environmental factors. Advanced age, low body mass index, preexisting vascular or endocrine disorders (e.g., hypothyroidism, diabetes), and impaired mobility are established patient-related risks. Procedural factors include the duration and invasiveness of surgery, use of neuraxial or general anesthesia, and exposure of large body surfaces. Environmental factors such as low ambient temperature and inadequate warming protocols further elevate risk. Recent studies emphasize the importance of preoperative temperature assessment and continuous intraoperative monitoring to identify high-risk individuals and tailor preventive interventions accordingly.
Perioperative hypothermia may present with subtle or overt clinical signs. Mild hypothermia (35–36°C) often manifests as shivering, cold extremities, and discomfort, while moderate to severe hypothermia (<35°C) can result in altered mental status, bradycardia, hypotension, arrhythmias, coagulopathy, and delayed recovery from anesthesia. Intraoperative hypothermia is frequently under-recognized due to the effects of anesthetic-induced vasodilation and impaired sensation. Postoperative complications such as increased wound infection rates, impaired drug metabolism, and prolonged hospitalization further underscore the clinical significance of timely detection and management.
Core temperature monitoring is the gold standard for the diagnosis of perioperative hypothermia. Recommended sites include the esophagus, nasopharynx, bladder, or pulmonary artery, depending on patient and procedural factors. Non-invasive cutaneous or tympanic membrane devices may be employed in selected settings, though they are less reliable for continuous monitoring. Early and frequent temperature assessments, beginning preoperatively and continuing through the intraoperative and immediate postoperative periods, are essential for prompt recognition and intervention.
Management of perioperative hypothermia centers on prevention, active warming, and treatment of established hypothermia. Preoperative strategies include patient education, pre-warming, and avoidance of cold environments. Intraoperative warming techniques encompass forced-air warming blankets, heated intravenous fluids, and maintenance of ambient operating room temperature. Postoperatively, continued use of active warming devices and vigilant monitoring are recommended until normothermia is restored. Pharmacologic interventions, such as antishivering agents, may be considered in refractory cases but are generally adjunctive. A multidisciplinary approach involving anesthesiologists, surgeons, and nursing staff is critical for successful implementation of warming protocols.
Recent advances in perioperative temperature management include the development of novel non-invasive core temperature monitors, improved forced-air and resistive heating devices, and personalized warming strategies based on real-time risk assessment. Artificial intelligence and machine learning algorithms are being explored to predict hypothermia risk using perioperative data, allowing for proactive interventions. Additionally, enhanced recovery after surgery (ERAS) protocols increasingly integrate temperature management as a core component, leading to improved compliance and outcomes. Ongoing research into pharmacologic modulation of thermoregulation and innovative warming technologies continues to expand the therapeutic armamentarium.
International guidelines, including those from the National Institute for Health and Care Excellence (NICE) and the American Society of Anesthesiologists (ASA), strongly advocate for routine perioperative temperature monitoring and the implementation of active warming measures for all patients at risk. Guideline-based protocols recommend preoperative identification of high-risk individuals, continuous intraoperative core temperature monitoring for all surgeries lasting over 30 minutes, and maintenance of normothermia throughout the perioperative period. Multimodal strategies encompassing patient education, environmental modifications, and standardized warming techniques are emphasized for optimal outcomes.
Risk stratification for perioperative hypothermia is a vital component of modern surgical care, with direct implications for patient safety and postoperative recovery. An understanding of the multifactorial etiology, identification of high-risk individuals, and adherence to evidence-based prevention and management protocols are essential for minimizing hypothermia-related complications. Advances in monitoring, warming technology, and predictive analytics hold promise for further reducing the burden of perioperative hypothermia. Ongoing education and multidisciplinary collaboration will be key to optimizing perioperative temperature management and enhancing surgical outcomes.
1.
Australian researchers attribute drop in melanoma rates to increasingly diverse population
2.
Scientists discover the 'roadmap' that aggressive cancer uses to spread
3.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
4.
Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy
5.
Scientists pioneer noninvasive 3D imaging to enhance skin cancer management
1.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
2.
Geriatric Assessment Before Systemic Cancer Therapy: Clinical Relevance and Evidence-Based Approaches
3.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
4.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
5.
Chronic Disease Clustering in Communities: Epidemiology, Mechanisms, and Clinical Implications
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation